• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不明原因的发育迟缓/学习障碍:一线评估及遗传/代谢/放射学检查的最佳实践方案指南

Unexplained developmental delay/learning disability: guidelines for best practice protocol for first line assessment and genetic/metabolic/radiological investigations.

作者信息

O'Byrne J J, Lynch S A, Treacy E P, King M D, Betts D R, Mayne P D, Sharif F

机构信息

Department of Clinical Genetics, Our Lady's Children's Hospital, Crumlin, Dublin 12, Ireland.

National Centre for Inherited Metabolic Disorders, Temple Street Children's University Hospital, Dublin 1, Ireland.

出版信息

Ir J Med Sci. 2016 Feb;185(1):241-8. doi: 10.1007/s11845-015-1284-7. Epub 2015 Apr 21.

DOI:10.1007/s11845-015-1284-7
PMID:25894277
Abstract

BACKGROUND

Investigation of patients, particularly children, with unexplained global developmental delay (GDD)/learning disability (LD) has been challenging due to a lack of clear guidance from specialised centres. Limited knowledge of rare diseases and a poor understanding of the purpose or limitations of appropriate investigations have been some of the principal reasons for this difficulty.

AIMS

A guideline development group was formed to recommend on appropriate, first line metabolic, genetic and radiological investigations for children and adults with unexplained GDD/ID.

METHODS AND RECOMMENDATIONS

A comprehensive literature search was conducted, evaluated and reviewed by the guideline committee and a best practice protocol for first line assessment and genetic, metabolic and radiological investigations was decided upon after considering diagnostic yield, practicality, treatability and costs.

CONCLUSION

It is hoped that these recommendations will become national guidelines for the first line metabolic, genetic and radiological investigation of patients presenting with unexplained GDD/ID.

摘要

背景

由于缺乏专业中心的明确指导,对患有不明原因的全面发育迟缓(GDD)/学习障碍(LD)的患者,尤其是儿童进行调查一直具有挑战性。对罕见病的了解有限以及对适当检查的目的或局限性认识不足是造成这一困难的一些主要原因。

目的

成立了一个指南制定小组,以推荐对患有不明原因的GDD/智力障碍(ID)的儿童和成人进行适当的一线代谢、遗传和放射学检查。

方法与建议

进行了全面的文献检索,由指南委员会进行评估和审查,并在考虑诊断率、实用性、可治疗性和成本后,确定了一线评估以及遗传、代谢和放射学检查的最佳实践方案。

结论

希望这些建议将成为对患有不明原因的GDD/ID患者进行一线代谢、遗传和放射学检查的国家指南。

相似文献

1
Unexplained developmental delay/learning disability: guidelines for best practice protocol for first line assessment and genetic/metabolic/radiological investigations.不明原因的发育迟缓/学习障碍:一线评估及遗传/代谢/放射学检查的最佳实践方案指南
Ir J Med Sci. 2016 Feb;185(1):241-8. doi: 10.1007/s11845-015-1284-7. Epub 2015 Apr 21.
2
Evidence report: Genetic and metabolic testing on children with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.证据报告:对全球发育迟缓儿童进行遗传和代谢检测:美国神经病学学会质量标准子委员会和儿童神经病学会实践委员会的报告。
Neurology. 2011 Oct 25;77(17):1629-35. doi: 10.1212/WNL.0b013e3182345896. Epub 2011 Sep 28.
3
Current evidence-based recommendations on investigating children with global developmental delay.关于对全面发育迟缓儿童进行调查的当前循证建议。
Arch Dis Child. 2017 Nov;102(11):1071-1076. doi: 10.1136/archdischild-2016-311271.
4
Yield of additional metabolic studies in neurodevelopmental disorders.神经发育障碍中额外代谢研究的产出
Ann Neurol. 2008 Aug;64(2):212-7. doi: 10.1002/ana.21435.
5
Update on the investigation of children with delayed development.发育迟缓儿童的调查进展
J Paediatr Child Health. 2013 Jul;49(7):519-25. doi: 10.1111/jpc.12176. Epub 2013 Apr 19.
6
Updates in the genetic evaluation of the child with global developmental delay or intellectual disability.全球发育迟缓或智力残疾儿童遗传评估的新进展。
Semin Pediatr Neurol. 2012 Dec;19(4):173-80. doi: 10.1016/j.spen.2012.09.004.
7
Practice parameter: evaluation of the child with global developmental delay [RETIRED]: report of the Quality Standards Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society.实践参数:对全面发育迟缓儿童的评估[已废止]:美国神经病学学会质量标准小组委员会及儿童神经病学会实践委员会报告
Neurology. 2003 Feb 11;60(3):367-80. doi: 10.1212/01.wnl.0000031431.81555.16.
8
Our experience with the aetiological diagnosis of global developmental delay and intellectual disability: 2006-2010.我们对全球发育迟缓与智力残疾病因诊断的经验:2006 - 2010年
Neurologia. 2014 Sep;29(7):402-7. doi: 10.1016/j.nrl.2013.10.006. Epub 2013 Dec 11.
9
The treatable intellectual disability APP www.treatable-id.org: a digital tool to enhance diagnosis & care for rare diseases.可治疗智力障碍 APP(www.treatable-id.org):一款用于增强罕见病诊断和治疗的数字工具。
Orphanet J Rare Dis. 2012 Jul 23;7:47. doi: 10.1186/1750-1172-7-47.
10
Treatable inborn errors of metabolism causing intellectual disability: a systematic literature review.可治疗的导致智力障碍的先天性代谢缺陷:系统文献回顾。
Mol Genet Metab. 2012 Mar;105(3):368-81. doi: 10.1016/j.ymgme.2011.11.191. Epub 2011 Nov 30.

引用本文的文献

1
DNA copy number variations and craniofacial abnormalities in 1,457 children with neurodevelopmental disorders.1457名神经发育障碍儿童的DNA拷贝数变异与颅面异常
Ital J Pediatr. 2025 Jan 23;51(1):9. doi: 10.1186/s13052-025-01839-6.
2
Genetic analysis of neurodevelopmental disorders in children.儿童神经发育障碍的遗传学分析
Front Child Adolesc Psychiatry. 2022 Dec 7;1:987339. doi: 10.3389/frcha.2022.987339. eCollection 2022.
3
INAHTA member agency stories of engaging, adaptable, and impactful HTA.国际卫生技术评估网络(INAHTA)成员机构关于引人入胜、适应性强且具影响力的卫生技术评估的故事。

本文引用的文献

1
Comprehensive evaluation of the child with intellectual disability or global developmental delays.对智力残疾或全面发育迟缓儿童的综合评估。
Pediatrics. 2014 Sep;134(3):e903-18. doi: 10.1542/peds.2014-1839.
2
Epidemiology of fragile X syndrome: a systematic review and meta-analysis.脆性X综合征的流行病学:一项系统评价和荟萃分析。
Am J Med Genet A. 2014 Jul;164A(7):1648-58. doi: 10.1002/ajmg.a.36511. Epub 2014 Apr 3.
3
The metabolic evaluation of the child with an intellectual developmental disorder: diagnostic algorithm for identification of treatable causes and new digital resource.
Int J Technol Assess Health Care. 2024 Dec 10;41(1):e4. doi: 10.1017/S0266462324004732.
4
Diagnostic Approach to Children with Unexplained Global Developmental Delay in Pediatric Neurology Outpatient Clinic.儿科神经科门诊对不明原因全面发育迟缓儿童的诊断方法
Neuropediatrics. 2025 Apr;56(2):125-132. doi: 10.1055/a-2430-0494. Epub 2024 Oct 7.
5
Intellectual Disabilities and Neurocognitive Impairment in Adult Patients with Inherited Metabolic Diseases: A UK Single Centre Experience.成人遗传性代谢病患者的智力障碍和神经认知障碍:英国单中心经验。
Genes (Basel). 2024 Jul 15;15(7):923. doi: 10.3390/genes15070923.
6
Genetic and metabolic investigations for neurodevelopmental disorders: position statement of the Canadian College of Medical Geneticists (CCMG).神经发育障碍的遗传和代谢研究:加拿大医学遗传学家学院(CCMG)的立场声明。
J Med Genet. 2023 Jun;60(6):523-532. doi: 10.1136/jmg-2022-108962. Epub 2023 Feb 23.
7
Pathogenic Copy Number Variations Involved in the Genetic Etiology of Syndromic and Non-Syndromic Intellectual Disability-Data from a Romanian Cohort.涉及综合征型和非综合征型智力障碍遗传病因的致病性拷贝数变异——来自罗马尼亚队列的数据
Diagnostics (Basel). 2022 Dec 12;12(12):3137. doi: 10.3390/diagnostics12123137.
8
Children, Adolescents, and Young Adults with Borderline Intellectual Functioning: Etiological, Neurophysiological, and Mri Findings in a Cohort of 651 Patients.边缘智力功能的儿童、青少年和青年:651例患者队列的病因、神经生理学和MRI结果
Neurol Int. 2022 Dec 7;14(4):1007-1017. doi: 10.3390/neurolint14040080.
9
Further characterization of the 9q31 microdeletion phenotype; delineation of a common region of overlap containing ZNF462.进一步描述 9q31 微缺失表型;描绘包含 ZNF462 的重叠常见区域。
Mol Genet Genomic Med. 2023 Mar;11(3):e2116. doi: 10.1002/mgg3.2116. Epub 2022 Dec 3.
10
Whole exome sequencing based identification of a case of cardiofaciocutaneous syndrome type 3: the benefits of new sequencing technology in children with neurodevelopmental delay.基于全外显子组测序鉴定的 3 型心面皮肤综合征病例:新技术在伴有神经发育迟缓儿童中的应用优势。
BMJ Case Rep. 2022 Nov 8;15(11):e251871. doi: 10.1136/bcr-2022-251871.
智力发育障碍儿童的代谢评估:可治疗病因的诊断算法和新的数字资源。
Mol Genet Metab. 2014 Apr;111(4):428-38. doi: 10.1016/j.ymgme.2014.01.011. Epub 2014 Jan 24.
4
Genetics and the investigation of developmental delay/intellectual disability.遗传学与发育迟缓/智力障碍的研究。
Arch Dis Child. 2014 Apr;99(4):386-9. doi: 10.1136/archdischild-2013-304063. Epub 2013 Dec 16.
5
Neurodevelopmental disorders and genetic testing: current approaches and future advances.神经发育障碍与基因检测:当前方法与未来进展
Ann Neurol. 2013 Aug;74(2):164-70. doi: 10.1002/ana.23950.
6
Fragile X syndrome testing in the North West.西北地区的脆性X综合征检测
Arch Dis Child. 2013 Mar;98(3):239. doi: 10.1136/archdischild-2012-302934. Epub 2013 Jan 18.
7
Newborn, carrier, and early childhood screening recommendations for fragile X.脆性 X 综合征的新生儿、携带者及婴幼儿筛查建议
Pediatrics. 2012 Dec;130(6):1126-35. doi: 10.1542/peds.2012-0693. Epub 2012 Nov 5.
8
Classical Galactosaemia in Ireland: incidence, complications and outcomes of treatment.爱尔兰的经典半乳糖血症:发病率、并发症和治疗结果。
J Inherit Metab Dis. 2013 Jan;36(1):21-7. doi: 10.1007/s10545-012-9507-9. Epub 2012 Jul 3.
9
Treatable inborn errors of metabolism causing intellectual disability: a systematic literature review.可治疗的导致智力障碍的先天性代谢缺陷:系统文献回顾。
Mol Genet Metab. 2012 Mar;105(3):368-81. doi: 10.1016/j.ymgme.2011.11.191. Epub 2011 Nov 30.
10
Evidence report: Genetic and metabolic testing on children with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.证据报告:对全球发育迟缓儿童进行遗传和代谢检测:美国神经病学学会质量标准子委员会和儿童神经病学会实践委员会的报告。
Neurology. 2011 Oct 25;77(17):1629-35. doi: 10.1212/WNL.0b013e3182345896. Epub 2011 Sep 28.